Tygh Capital Management, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2020$3,475,000
+33.7%
51,600
+67.3%
0.78%
+81.6%
Q4 2019$2,599,000
-39.3%
30,847
-75.9%
0.43%
-52.2%
Q4 2018$4,285,000
-61.9%
127,973
-40.3%
0.90%
-51.1%
Q3 2018$11,236,000
+43.2%
214,431
-14.5%
1.84%
+38.2%
Q2 2018$7,849,000250,7691.33%
Other shareholders
NOVOCURE LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders